Autopsy report · NCT02385500

Fesoterodine on Urgency Episodes in Parkinson's Disease Population

“Insufficient or untimely patient recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 6 months before it started.
• Ran for about 2 years 9 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Sir Mortimer B. Davis - Jewish General Hospital

Sponsor type

University, hospital or other

Conditions

Urinary Bladder, Overactive; Parkinson Disease

Interventions

Fesoterodine; Placebo

Participants

5

Sites

1

Countries

Canada

Trials that died the same way

• Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia
  “Patient recruitment insufficient” (95% match in meaning)
• Daptomycin in Pediatric Patients With Bacterial Meningitis
  “Insufficient patient recruitment” (93% match in meaning)
• Near Infrared Spectroscopy in Patients Undergoing Robotic Assisted Laparoscopic Surgery in the Trendelenburg Position
  “No sufficient patient recruitment” (92% match in meaning)
• Growth Hormone in Poor Responders to IVF Trial
  “Insufficient/slow patient recruitment” (91% match in meaning)
• Macular Edema Incidence/Severity Reduction With Nevanac
  “Patient recruitment difficulties” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.